View Older Stories View More Recent Stories
-
The Deal Reports Rise In Small-Cap Equity Financing Dollars Invested For Q1 2015; Slight Decline In Volume Of Transactions
-
Veracyte (VCYT) Enters 4.91M Common Private Placement at $8.15/Share
-
Veracyte, Inc. Announces $40 Million Private Placement
-
Form SC 13G Carbylan Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G Ohr Pharmaceutical Inc Filed by: Broadfin Capital, LLC
-
Cynapsus Therapeutics Announces CAD$21 Million Private Placement
-
Form SC 13G CARDICA INC Filed by: Broadfin Capital, LLC
-
Form SC 13G Ignyta, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13D/A DERMA SCIENCES, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G ADMA BIOLOGICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13D DERMA SCIENCES, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G ZOGENIX, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G BioLineRx Ltd. Filed by: Broadfin Capital, LLC
-
Form SC 13G RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC
-
Advaxis (ADXS) Sells 3.1M Shares in Direct Offering at $7.50/Share
-
Advaxis Completes $23 Million Financing
-
Form SC 13G/A IDERA PHARMACEUTICALS, Filed by: Broadfin Capital, LLC
-
Form SC 13G Biodel Inc Filed by: Broadfin Capital, LLC
-
Form SC 13G Tonix Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G/A DERMA SCIENCES, INC. Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Dec 31
-
Form SC 13G/A Amphastar Pharmaceutical Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ANGIODYNAMICS INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Biota Pharmaceuticals, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CAS MEDICAL SYSTEMS INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Celsus Therapeutics Plc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A DEPOMED INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Eleven Biotherapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A FLAMEL TECHNOLOGIES SA Filed by: Broadfin Capital, LLC
-
Form SC 13G/A LA JOLLA PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Emergent BioSolutions Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aegerion Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Anthera Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Tonix Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A AMAG PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Retrophin, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Horizon Pharma plc Filed by: Broadfin Capital, LLC
-
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G CATALYST PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Ohr Pharmaceutical (OHRP) Closes 4.26M Common Offering; Gross Proceeds at ~$28.8M
-
Form SC 13G EPIRUS Biopharmaceutical Filed by: Broadfin Capital, LLC
-
Form SC 13G ALCOBRA LTD. Filed by: Broadfin Capital, LLC
-
Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
-
PlacementTracker Publishes 2014 PIPE Market League Tables
-
Form SC 13D/A CARDICA INC Filed by: Broadfin Capital, LLC

